Nyxoah SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nyxoah SA - overview
Established
2009
Location
-, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Established in 2009 and based in Mont-Saint-Guibert, Belgium, Nyxoah SA operates as a medical device company that engages in the development of novel diagnostic and therapeutic solutions for obstructive sleep apnea (OSA). In March 2023, Nyxoah S. A. raised USD 3 million in PIPE funding.
The company develops GENIO™, a neurostimulator designed to control the nerve of the tongue and prevent airway blockage that enables normal breathing. The implant designed by the company sends impulses to the two branches of the hypoglossal nerve to help people suffering from moderate to high obstructive sleep apnea sleep better.
Current Investors
Glide Healthcare, SRIW, Cochlear Limited
Primary Industry
Medical Devices & Equipment
Sub Industries
Molecular Science, Genetics & Gene Therapy, Therapeutic Devices
Website
www.nyxoah.com
Verticals
HealthTech, Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Nyxoah SA - timeline of key events
Nyxoah SA - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - | 69,160 | 862,860 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | 1147.6% | - | - | - |
| EBITDA (USD) | (138,835) | (774,713) | (2,491,953) | (3,401,152) | 3,016,570 | (2,135,043) | (11,114,081) | (7,000,672) | (8,387,059) | (5,265,112) | (8,536,798) | (24,778,551) | - | - | - |
| Operating Income (USD) | (139,695) | (776,511) | (2,500,745) | (3,412,503) | (764,172) | (4,108,602) | (11,153,547) | (7,042,864) | (8,430,028) | (5,305,342) | (8,977,137) | (27,825,103) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | (12980.2%) | (3224.8%) | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - | (12343.5%) | (2871.7%) | - | - | - |
| NET Income (USD) | (153,060) | (812,253) | (2,559,559) | (3,485,387) | (907,326) | (4,238,694) | (11,291,401) | (7,571,185) | (8,900,415) | (6,665,975) | (11,125,675) | (27,021,311) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - | (16086.9%) | (3131.6%) | - | - | - |
Nyxoah SA - employee data
Nyxoah SA - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Member of the Board of Directors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.